Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

Gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI, in rheumatoid synovitis, 1610
Gait, in diagnosis of lumbar spinal stenosis, 1236
Galactoside fusion protein, β, autoepitopes of 52-kd SS-A/Ro molecule and, 990
Gamma-irradiated ELISA, to study anti-apolipoprotein A1 in SLE and, 1655
Gamma response region, cytokines, early response genes and, 877
γ/δ T cell receptors, Klebsiella pneumoniae-reactive T cells in AS and, 1277
Ganglia, dorsal root, substance P and calcitonin gene-related peptide in rat adjuvant arthritis, 699
Gastroduodenal injury, NSAID-induced, in children, 1225
Gastrointestinal bleeding, after Chinese herbal medications plus prescription drugs, 614
Gastrointestinal involvement
adverse reactions in RA and, 1447, 1595, 1799
after corticosteroids, pulse cyclophosphamide and plasma ex
Gastrointestinal involvement (cont'd)
change in polyarteritis nodosa and Churg-Strauss syndrome, 1638
draft guidelines for drugs in JRA clinical trials and, 715
tiludronate, etidronate and, in Paget's disease of bone, 851
Gastrointestinal tract, immunosuppressive drugs during pregnancy and, 1722
Gel electrophoresis
agarose, to study apoptosis in RA synoviocytes, 485
agarose-polyacrylamide, to study proteoglycan synthesis in canine OA, 525
denaturing gradient, to study COL2A1 gene mutation in chondrodysplasias and familial OA, 999
sodium dodecyl sulfate-polyacrylamide, carbohydrates in RA immune complexes and, 744
Gel permeation-liquid chromatography, high-performance, to study TGFβ1 in hyaluronan synthesis in synovial lining cells, 669
Gelatin zymography, Arg-Gly-Asp (RGD) peptide, IL-1, chondrocytes, matrix metalloproteinase synthesis and, 1304
Gelatinase, Arg-Gly-Asp (RGD) peptide, IL-1, chondrocytes, matrix metalloproteinase synthesis and, 1304
Gender
autoimmunity and, 301, 1532
cytarabine in refractory cutaneous lupus and, 1341
elastin, collagen degradation and, in SSc, 517
epidemiology of polymyalgia rheumatica in Olmsted County, MN and, 369
erythrocytes in rheumatoid vasculitis and, 248
factors affecting bone mass and, 61
in fibromyalgia, 19, 161, 229, 235, 926
immunosuppressive drugs during pregnancy and, 1722
loosening of revision total hip replacement and, 1335
number of children, low back pain and, 1232
in OA, 448, 539, 799, 907, 1134, 1500
in prevalence studies, 19, 551
in RA, 49, 601, 902, 1120, 1328
racial factors in gout and, 628
radiographic joint space measurement and, 891
silicone breast implants and, 719
in SLE, 274, 506, 551, 826, 1260, 1475, 1492
vitamin B6 in rheumatoid cachexia and, 105
Gene-related peptides, calcitonin, substance P and, in rat adjuvant arthritis, 699
General Considerations for the Clinical Evaluation of Drugs in Infants and Children (American Academy of Pediatrics), 715
Genes
aggrecan and collagen, in experimental OA, 420
childhood sexual abuse, fibromyalgia and, 161, 229, 235
COL2A1, mutation of, in chondrodysplasias and familial OA, 999
collagen, in scleroderma in Tsk2 mouse, 1791
complement, 1715
DNA binding of IgM[gl] anti-DNA antibody and, 389
early response, cytokines and, 877
germline, autoantibodies in twins with scleroderma and, 1845
HLA, 1715
human monoclonal antiphospholipid antibody and, 1068
IgG receptors in autoimmune disease and, 306
IL-1α, in JRA, 221
MHC, anti-U1 RNP antibody and, 396
in occurrence of AS in twins in Finland, 381
polyglot, polymorphism and, 1715
in RA, 91, 477, 577, 1242, 1754
in SLE, 110, 1655
TAP, Reiter's syndrome and, 684
Vβ, 458, 1077, 1242
variable region, 1068
Genetics
autoimmune disease induction by microbial pathogens and, 458
autoimmunity and, 301, 1532
bone mass and, 57
childhood sexual abuse, fibromyalgia and, 161, 229, 235
enteroviral RNA, bacterial DNA and, in juvenile DM, 1513
gold-induced enterocolitis, HLA-DRB1*0404 allele and,
755
HLA type in MCTD, 259
IgG receptors in autoimmune disease and, 306
IL-1α polymorphism in JRA, 221
in Lyme borreliosis, 565
mapping of, in scleroderma in Tsk2 mouse, 1791
occurrence of AS in twins in Finland, 381
polyglot, polymorphism and, 1715
in RA, 91, 1754
TAP alleles, Reiter's syndrome and, 684
typing of, in inflammatory arthritis, 873
Genomes, autoimmune disease induction by microbial pathogens and, 458
Genotypes
Lyme borreliosis and, 565
shared-epitope DRB1 alleles, RA gene and, 1754
Genotyping
autoantibodies in twins with scleroderma and, 1845
MHC class II genes, anti-U1 snRNP antibody and, 396
polymerase chain reaction-based, to study immunoglobulin κ and RA, 1526
Geographic clusters of SLE, 1564
Germinal centers, activation markers in RA synovial membrane and, 1346
Germline-encoded human monoclonal antiphospholipid antibody, 1068
Germline genes, autoantibodies in twins with scleroderma and, 1845
Gestation, immunosuppressive drugs during pregnancy and, 1722
Giant cell arteritis (GCA)
See also temporal arteritis
anemia in, 434
brain abscess mimicking, 1710
eosinophil major basic protein in SSc and, 939
immunosuppressive drugs during pregnancy in, 1722
infection and onset of, 374
internal elastic lamina in, 1733
Glands, salivary, T cell receptor Vβ genes in Sjogren's syndrome and, 1077
Global assessment
patient, 601, 618, 1568, 1826
physician, 601, 618, 727, 1568, 1826
in RA, 601, 819, 1568
in SLE, 1826
Glomerulonephritis
C4 deficiency in, 1333
renal biopsy in RA and, 242
Glu, MHC class II genes, anti-U1 snRNP antibody and, 396
Glucocorticoid drugs
during pregnancy, 1722
low-dose systemic, MRI, PET and, in RA, 819
Glucose metabolism, MRI, PET and, in RA, 819
Glutathione-S-transferase-conjugated agarose beads, HRES-1 antibodies, in SLE and overlap syndromes, 1660
Glycolipids, in Lyme borreliosis, 565
Glycoprotein 1, β2, cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein and, 1362
Glycosaminoglycans
cartilage and, 173, 660
epitopes, in knee joint fluid after trauma, 953
Glycosylation
carbohydrates in RA immune complexes and, 744
IgG receptors in autoimmune disease and, 306
GLY-X-Y sequence of collagen, Yersinia enterocolitica adhesin YadA binding to, 1283
Gold-induced enterocolitis, HLA-DRB1*0404 allele and, 755
Gold labeling immunoelectron microscopy, Chlamydia trachomatis in synovial membrane and, 1410
Gold in RA
cost of, 318
renal biopsy and, 242
Gottron's papules, acanthosis nigricans and, 862
Gout
racial factors in, 628
spinal involvement in, 139
Gouty arthritis
in AIDS, 570
untreated, finger autoamputation secondary to, 1241
GP-1-515, antiinflammatory mechanism of adenosine regulators and, 1040
gp46 envelope protein, HTLV, HTLV-1 in PM and, 690
Gradient gel electrophoresis, denaturing, to study COL2A1 gene mutation in chondrodysplasia and familial OA, 999
Gram staining, in pseudoseptic inflammatory knee effusion in sickle cell disease, 284
Granular lymphocytes, large, hematology of Felty's syndrome and, 1252
Granule proteins, eosinophil major basic protein in SSc and, 939
Granulocyte-macrophage colony-stimulating factor
cytokines, early response genes and, 877
IgM-RF in bone marrow cells in RA and, 381
Granuloma, tuberculous and foreign-body granulomatous reactions in total knee prosthesis and, 1325
Granulomatosis, Wegener's
antineutrophil cytoplasmic antibodies in mice and, 1375
immunosuppressive drugs during pregnancy in, 1722
MTX and prednisone in, 608
Granulomatous synovitis, in hydatid disease in chronic monarthritis, 1339
Granzyme A, perforin and, in RA synovium, 477
Grip strength in RA
in every-other-week MTX, 601
in outcome measures in clinical trials, 1568
GroEL Escherichia coli, Klebsiella pneumoniae-reactive T cells in AS and, 1277
Gross National Product, impact of musculoskeletal conditions and, 1351
Growth and development, chondrocytes in, 960
Growth factors
chondrocytes in aging and development and, 960
early response genes and, 877
epidermal, 877
insulin-like 1, in OA, 413
platelet-derived, 877, 960
transforming β1, in hyalyronan synthesis in synovial lining cells, 669
Growth hormone, insulin-like growth factor 1 in OA and, 413
Guanidine, proteoglycans in articular cartilage in OA and RA and, 660
Guanylate binding protein gene, cytokines and, 877
Guidelines for the Clinical Evaluation of Antiinflammatory and Antirheumatic Drugs in Children (FDA), 715
Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations (American Academy of Pediatrics), 715
Guidelines for the medical management of OA
hip, 1535
knee, 1541